NR1H4 and Disorder of lipid metabolism: Conversely, dysbiosis-induced alterations in BA composition can impair both farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5) signaling, thereby aggravating lipid metabolism disorders and vascular inflammation, which are central to the pathophysiology of AS and CVD [20, 21].